Health Condition 1: null- Lung Cancer Patients
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age >= 18 years 2) Patients diagnosed with stage IV NSCLC 3) Patients planned and administered gefitinib as palliative treatment 4) ECOG Performance Status 0-3
Exclusion criteria
Exclusion criteria: 1) Age 2) Patients with lung cancers other than NSCLC 3) Patients with active cancer other than NSCLC
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall Survival in patients of NSCLC on gefitinibTimepoint: At the end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Progression free survival in patients of NSCLC on gefitinib 2. Toxicities of Gefitinib 3. Quality of life of patients on Gefitinib 4. Factors affecting overall survival of patients receiving gefitinib 5. Response Rate Timepoint: 1. At Disease Progression 2. At every Visit 3. At every follow up visits 4. At the End of last follow up 5. Every 2-3 months | — |
Countries
India
Contacts
Public ContactDr Vibhor Sharma
Tata Memorial Hospital
Outcome results
None listed